AGNIQUE CSO-35

WHAT IS AGNIQUE CSO-35?

Agnique CSO-35, also known as Castor Oil Ethoxylate 35 EO, Polyoxyethylene (35) Castor Oil and POE 35 Castor Oil, is a commercial ethoxylated vegetable oil surfactant intended for formulation work where organic ingredients must interact effectively with an aqueous environment. This castor oil ethylene oxide adduct combines a castor oil-derived structure with polyoxyethylene chains introduced through ethoxylation. The description polyoxyethylene (35) castor oil indicates an average level of ethylene oxide addition, not an identical count in every molecule.

The commercial material contains related species with a distribution of structures, which makes the specified grade more informative than a simplified molecular drawing. The principal role of this polyethoxylated castor oil is emulsification, with additional wetting and formulation effects possible in suitable systems. A technical team should define which function is needed before choosing the concentration, partner emulsifier and manufacturing route.

For example, an EC may need an emulsifier that supports dispersion only after the concentrate enters water, whereas an EW must maintain an emulsion throughout storage. The same castor oil ethoxylate 35 EO can be relevant to both architectures while requiring a different dosage or blend. Agnique CSO-35 should be regarded as one ingredient in a designed system. Active solubility, droplet stability, particle dispersion, biological performance and packaging compatibility remain distinct requirements that no single surfactant automatically satisfies.

Common Product and Chemical Names

- Agnique CSO-35
- Ethoxylated castor oil
- Castor oil ethoxylate
- Castor oil, ethoxylated
- Castor oil ethoxylate 35 EO
- Ethoxylated castor oil 35 EO
- POE 35 castor oil
- Polyoxyethylene castor oil
- Polyoxyethylene (35) castor oil
- Polyethoxylated castor oil
- Castor oil polyoxyethylene ether
- Castor oil ethylene oxide adduct
- PEG-35 CASTOR OIL: Related ingredient nomenclature, subject to supplied-grade confirmation
- Polyoxyl 35 castor oil: Related chemical terminology, without implied pharmacopoeial equivalence

Ethoxylated castor oil is a family description for Agnique CSO-35, while POE 35 castor oil identifies the approximate average ethoxylation level. Polyoxyethylene castor oil describes the polyether-containing character responsible for much of the material's interaction with water. The descriptions polyethoxylated castor oil and castor oil polyoxyethylene ether can be used in technical discussion, but they do not erase differences between commercial grades.

A product sold as generic castor oil ethoxylate must still be assessed for EO level, quality limits and practical performance. Names such as hydrogenated castor oil ethoxylate, sulfated castor oil and Turkey red oil describe different chemistry. They should not appear as interchangeable synonyms for Agnique CSO-35.

Pharmaceutical grades and pharmacopoeial excipients also require their own identity and quality documentation. A shared description of polyoxyl 35 castor oil does not establish that an industrial emulsifier can replace a regulated excipient.

CAS NO, EC / EINECS NO AND INCI NAME

- Product name: Agnique CSO-35
- Chemical description: Castor oil ethoxylate, approximately 35 EO
- CAS No.: 61791-12-6
- EC / List No.: 500-151-7
- EINECS clarification: Use the EC / List designation for this 500-series entry rather than implying a conventional EINECS inventory number
- Related INCI name: PEG-35 CASTOR OIL
- Grade-specific cosmetic status: Obtain an explicit manufacturer or supplier declaration
- Chemical class: Nonionic ethoxylated oil surfactant
- Feedstock contribution: Castor oil-derived organic structure
- Commercial product identifier: 30634576
- Molecular formula: No single exact formula represents all components of the commercial material
- Molecular weight: Distributed; a single definitive value is not assigned here
- Main technical functions: Emulsifier, wetting support and formulation auxiliary

The CAS identifier covers the substance family described as "castor oil, ethoxylated" rather than independently defining a 35 EO grade. The purchase description should retain the exact commercial name and the relevant specification so material with another ethoxylation level is not accepted unintentionally. PEG-35 CASTOR OIL is useful for nomenclature recognition, but its presence in an ingredient inventory is not a certificate for the supplied industrial product.

Cosmetic, pharmaceutical and food-related uses need separate assessment of quality and the intended exposure. A fixed molecular weight would create a misleading impression of uniformity. The oil composition and ethoxylation distribution make Agnique CSO-35 different from a single purified small molecule with a unique formula and mass.

Substance identity also differs from batch conformity. A COA, agreed analytical limits and application testing provide information that a registry number cannot supply on its own.

PHYSICAL AND CHEMICAL PROPERTIES

- Appearance: Cloudy yellow liquid in product-specific technical information
- Physical form at 23 °C: Liquid
- Concentration: Approximately 100%
- Density at 23 °C: Approximately 1.04 g/cm3, DIN 51757 method 1
- Indicative HLB: Approximately 12.5–13; confirm the supplied grade specification
- Viscosity at 60 °C: Approximately 120 mPa.s
- Room-temperature viscosity: Verify against current grade data; the historical TDS contains inconsistent 23 °C entries
- pH: Approximately 7, measured in the defined EN 1262 solution B preparation
- Acid value: Approximately 0.5 mg KOH/g, ISO 2114
- Saponification value: Approximately 68 mg KOH/g, ISO 3681
- Dropping point: Approximately 20 °C, DIN 51801
- Congealing point: Approximately 5 °C, ISO 2207
- Pour point: Approximately 2 °C, ISO 3016
- Surface tension: Approximately 41 mN/m at 1 g/l in distilled water at 23 °C, EN 14370
- Cloud point, EN 1890 method A: Above 100 °C
- Cloud point, EN 1890 method B: Approximately 67 °C
- Cloud point, EN 1890 method C: Approximately 57 °C
- Cloud point, EN 1890 methods D and E: Approximately 72 °C
- Water behavior: Clear mixture in the stated 10% TDS tests at 23 °C
- Mineral oil behavior: Phase separation in the stated 10% TDS test at 23 °C
- Hygroscopicity: Relevant to storage and raw material handling
- Dilution behavior: Intermediate water additions can produce strong thickening or gel formation
- Boiling point: No single product value established here for this distributed surfactant material
- Flash point: Above 200 °C as indicative data; confirm the current SDS
- Water content acceptance limit: Establish from the current agreed specification

These Agnique CSO-35 figures are typical technical descriptions, not a complete guaranteed purchase specification. Density, viscosity and phase behavior should always be evaluated at the temperature and concentration relevant to the actual process. The historical product document contains conflicting room-temperature viscosity figures in its property and temperature tables.

A buyer designing pumps or setting acceptance limits should resolve that discrepancy through current product data or direct measurement rather than selecting a convenient number. Cloud point values belong to their prescribed test media, and the different results are not contradictions. Salt-containing and glycol ether-containing preparations change the castor oil ethoxylate environment, so a method-qualified value is more useful than an isolated temperature.

The typical Agnique CSO-35 dropping, congealing and pour points describe different test responses. None should be substituted automatically for another or interpreted as a guarantee of easy pumping throughout the entire low-temperature range.

MOLECULAR STRUCTURE AND AMPHIPHILIC FUNCTION

Agnique CSO-35 has a castor oil-derived portion that supplies affinity for organic environments, while its polyoxyethylene segments provide a hydrophilic contribution. This combination enables related molecular species to arrange at an interface between oil and water. Castor oil contains a substantial ricinoleic acid-derived contribution with hydroxyl functionality relevant to ethoxylation.

The resulting polyethoxylated castor oil is structurally more complex than a simple hydrocarbon chain joined to one small polar head group. The ether oxygen atoms in the polyether portion of POE 35 Castor Oil interact with surrounding water, helping form a hydrated region. When the oil-derived portion associates with a droplet, that hydrated region can extend into the aqueous phase and support steric stabilization.

These interactions do not mean that every ingredient becomes molecularly dissolved. A formulation may contain droplets, micellar structures or other aggregates whose properties differ from those of a simple solution. The useful molecular explanation therefore connects directly to the intended architecture. Interfacial adsorption supports emulsion design, while bulk compatibility and aggregation behavior influence how the raw castor oil ethoxylate can be incorporated during manufacture.

AVERAGE EO NUMBER AND COMMERCIAL DISTRIBUTION

Agnique CSO-35 has an approximate 35 EO number that expresses a grade characteristic rather than a uniform molecular composition. Individual species differ in chain length and structure, and their combined behavior determines the practical properties of the supplied product. Increasing the average EO contribution generally moves the balance toward greater hydrophilic character within a related series.

However, that trend does not predict every aspect of emulsification, viscosity or compatibility with a particular solvent. Distribution can matter when two nominally similar products give different cloud point or concentrate appearance. The discrepancy should be investigated through grade information and performance trials rather than dismissed because the average number matches.

Natural feedstock variation and manufacturing control can also influence composition. An agreed specification helps define the acceptable commercial material, while a formulation trial shows whether that range is appropriate to the process. For purchasing, specify the exact grade rather than requesting any 35 EO castor oil. A nominally equivalent sample becomes an approved alternative only after it meets the relevant identity, quality and functional criteria.

HYDRATION, STERIC BARRIERS AND TEMPERATURE

Agnique CSO-35 is a nonionic emulsifier that can stabilize droplets through the arrangement and hydration of its interfacial layer. In polyoxyethylene castor oil, the hydrated polyether region can reduce the ease with which neighboring droplets make direct contact. The barrier depends on adequate coverage and a favorable surrounding environment.

Too little emulsifier, unsuitable carrier composition or changes in hydration can weaken stabilization even if the Agnique CSO-35 material is chemically unchanged. Temperature alters the interactions of ethoxylated segments in Agnique CSO-35 with water and can change the preferred phase arrangement. The finished emulsion should therefore be tested at realistic manufacturing and storage temperatures rather than judged at one room-temperature point.

Salts and other dissolved components can produce a similar shift in behavior. Nonionic character does not make the interfacial layer independent of water chemistry, particularly in concentrated electrolyte systems. The practical advantage is the ability to combine this hydration-based mechanism with complementary surfactants. A mixed package can provide useful flexibility, provided its components remain compatible and support the intended interface under use conditions.

HLB AS A SCREENING TOOL

Agnique CSO-35 has an indicative HLB around 12.5 to 13, describing a relatively hydrophilic balance useful for considering oil-in-water systems. It helps position Agnique CSO-35 among possible emulsifiers without establishing a universal optimum for every carrier. The required balance is affected by the active-containing organic phase and its other ingredients.

An emulsifier package selected for one solvent blend may fail when the carrier changes, even if the active concentration remains the same. A calculated HLB for this castor oil ethoxylate is particularly limited when used to compare structurally different families. Equal numbers can conceal differences in interfacial packing, adsorption rate, water response and the physical distribution of commercial components.

Use the estimate to choose a manageable first trial series, then select on measured performance. Concentrate compatibility, initial dilution, standing behavior, foam and temperature response all contribute information beyond the nominal balance. If a project changes the active loading or introduces another active, review the castor oil ethoxylate package again. The operating window belongs to the complete formulation rather than to a numerical label attached to one ingredient.

EMULSIFICATION AND INTERFACIAL COVERAGE

Agnique CSO-35 requires an emulsifier system capable of supporting the new interfacial area created when droplets are produced. POE 35 castor oil can participate at that interface when the oil phase and aqueous environment favor its arrangement. Smaller droplets create more area at the same dispersed-phase volume, increasing the coverage requirement.

A change in homogenization can therefore alter the castor oil ethoxylate demand without any change in the ingredient percentages. Good initial dispersion with Polyoxyethylene (35) Castor Oil does not establish long-term resistance to coalescence. Observe droplet growth, oil release and the response after the formulation has stood under the relevant conditions.

A mixed emulsifier layer containing Agnique CSO-35 may provide a better result than either component alone. The useful blend ratio must be determined for the particular carrier, with commercial surfactant concentration and solvent content included in the calculation. Interfacial performance should also be connected to practical handling. A formulation that requires unrealistic mixing energy to form an acceptable dispersion can be unsuitable even if a laboratory homogenizer produces attractive droplets.

SOLUBILIZATION AND EMULSIFICATION ARE DIFFERENT FUNCTIONS

Agnique CSO-35 can participate in solubilization, which involves incorporating a small organic load into surfactant-associated structures, and in emulsification, which maintains a dispersed organic phase. Both can produce uniform mixtures, but their concentration limits and stability mechanisms differ. A clear sample may be suitable for a product requiring transparency, yet clarity alone does not identify its internal structure.

Temperature, dilution and additional ingredients can reveal how POE 35 Castor Oil behaves in ways behavior not visible in the initial sample. Agnique CSO-35 can be evaluated where its relatively hydrophilic character supports distribution of a suitable organic ingredient. The amount it can accommodate depends on that ingredient, water composition and any co-solvent or co-surfactant.

For a high oil loading, design the product as an emulsion if that is the intended architecture. Increasing surfactant until a sample becomes clear can create excessive viscosity or another unwanted phase rather than a commercially useful solution. Development should start with the required appearance and function. This avoids spending time forcing a transparent structure into an application that would work better as a stable, controlled emulsion.

WETTING AND APPLICATION CONTACT

Agnique CSO-35 can help a liquid contact the intended surface before its active ingredient or cleaning solvent performs effectively. Castor oil ethoxylate 35 EO can contribute to that contact by modifying the behavior of the liquid interface. The result depends on the final use concentration and the properties of the surface.

A measurement on glass cannot represent every leaf, polymer or industrial deposit that a formulated product may encounter. Equilibrium surface tension is useful, but spraying and rapid spreading involve surfaces that have existed for a short time. Dynamic measurements or realistic application comparisons can provide information that a single equilibrium value misses.

Wetting with Agnique CSO-35 should also be distinguished from penetration, retention and biological action. A larger spread area is an observation, not automatic proof of stronger uptake or better pest control. For industrial use, assess whether improved contact leaves acceptable residues or affects the substrate during prolonged exposure. The practical selection needs to cover the whole operation rather than only the first moment of spreading.

PROBLEMS ADDRESSED IN ORGANIC CONCENTRATES

Agnique CSO-35 can be considered when an organic concentrate disperses poorly into water because its emulsifier package does not match the carrier-active phase. Polyoxyethylene (35) Castor Oil offers a nonionic contribution to investigate when free oil or unstable droplets indicate an interfacial limitation. The material can also help design a blend that responds adequately to realistic mixing rather than laboratory-only high shear.

This is valuable where the user prepares a dilution in a tank with limited agitation. Before attributing a failure to emulsification, verify active ingredient solubility in the original concentrate. A solvent deficit can produce crystals that remain visible after dilution and cannot necessarily be corrected by adding more surfactant.

Organic-phase compatibility of the 35 EO castor oil ethoxylate is equally important because a relatively hydrophilic emulsifier can separate from some carrier systems. A useful co-emulsifier or co-solvent may be needed to maintain a uniform concentrate before its water-dilution performance is assessed. The development question should therefore be specific. Better initial dispersion, a wider water tolerance range and improved standing stability are different targets and may favor different formulation adjustments.

BENEFITS TO MANUFACTURERS AND PRODUCT USERS

Agnique CSO-35 can contribute to a reproducible route from ingredients to a uniform product when the chosen emulsifier package is suitable. Agnique CSO-35 can contribute to that reproducibility where its compatibility and interfacial behavior match the process. A practical dilution system reduces the effort needed to prepare a consistent use mixture.

The benefit should be demonstrated with the intended addition order, water quality and mixing intensity rather than inferred from an attractive concentrate. Physical stability can reduce waste associated with rejected batches or deposits during use. Those commercial gains belong to the validated formulation and should be quantified where they influence a purchasing decision.

A mixed nonionic-anionic package containing Agnique CSO-35 also gives developers room to tune competing requirements. The blend may balance concentrate uniformity, droplet stability and water response more effectively than a single ingredient selected without comparison. The strongest benefit is a dependable operating range under defined conditions. A surfactant that succeeds at one convenient test point offers less value than a formulation that tolerates the ordinary variations expected in manufacture and service.

CLOUD POINT METHODS AND ELECTROLYTE EFFECTS

Agnique CSO-35, as an ethoxylated material, has a cloud point that reflects its behavior in a specified test environment. Different media can change hydration and produce different temperatures without indicating that the underlying product identity has changed. The product-specific technical information gives separate values for water, salt-containing and glycol ether-containing methods.

Those method qualifications should remain attached to any value used for technical comparison. For a saline agricultural mixture or cleaner, the pure-water result cannot establish the relevant temperature behavior. Test the finished composition because salts, solvents and other surfactants jointly influence its structure.

Clouding of the ethoxylated castor oil system may be reversible on cooling, but that does not prove that the droplet distribution remains unchanged. A temporary shift can lead to coalescence or another permanent change in an otherwise reversible surfactant transition. Cloud point is therefore a useful clue for selecting test conditions rather than a universal maximum process temperature. The acceptable operating range must also respect active stability, auxiliary compatibility and equipment constraints.

GEL FORMATION DURING WATER DILUTION

Agnique CSO-35 can pass through highly structured intermediate compositions when water is added to the concentrated ethoxylated surfactant. The result may be a strong viscosity increase even when both the starting material and final dilute solution are easier to handle. Agnique CSO-35 is specifically associated with this type of dilution concern in technical information.

A formulator should consider the entire addition path rather than only the appearance of the finished mixture. Slowly pouring water into a surfactant-rich zone can create a viscous region that the mixer struggles to disperse. Local composition may remain trapped near that region even though the intended final water content would give a more fluid product.

A defined Agnique CSO-35 premixing route, controlled addition or compatible solubilizing aid may provide a better process. Each option should be evaluated for its effect on finished performance rather than chosen only because it reduces an immediate mixing difficulty. Scale-up needs particular attention because a large vessel can develop local gradients not present in a small beaker. Record the successful laboratory sequence and confirm it in representative equipment before adopting the recipe commercially.

WATER, ALCOHOL AND OIL COMPATIBILITY

Agnique CSO-35 has manufacturer tests that distinguish compatibility in defined media from a general claim of universal solubility. POE 35 Castor Oil can behave differently in water, alcohol, aromatic carriers and mineral oil because those environments support different molecular interactions. A clear aqueous test does not prove that the material will remain clear after adding an active ingredient or another surfactant.

The additional organic load may exceed the capacity of the Agnique CSO-35 system and the capacity of the selected structure or change phase behavior. Likewise, poor compatibility in a simple mineral oil test does not automatically rule out every oil-containing formulation. A suitably designed mixture of carrier, co-emulsifier and co-solvent may provide a workable concentrate.

Test the complete organic phase before making broad substitution decisions. This avoids accepting a surfactant that performs well after water dilution but separates from the supplied product during storage. Compatibility observations should specify concentration, temperature and standing time. A label such as soluble is too incomplete to guide process selection when the real product will encounter a different composition or storage condition.

EMULSIFIABLE CONCENTRATE APPLICATIONS

Agnique CSO-35 can be part of an EC emulsifier package that allows an active ingredient dissolved in organic carriers to disperse after addition to water. Castor Oil Ethoxylate 35 EO can be part of that package where it matches the active-containing phase. The concentrate must first satisfy its own solubility and storage requirements.

Assess clarity or allowable appearance, crystallization and phase uniformity before using water-dilution results to select a preferred formulation. During dilution, solvent and surfactant redistribution can change the local environment around the active. A formulation that is stable before dilution can therefore create crystals or active-rich deposits as the water fraction increases.

Evaluate a realistic dilution path and standing period rather than only a freshly shaken mixture. Record oil release, cream, sediment and foam separately so the next adjustment targets the actual mechanism. The finished EC also needs chemical stability and crop response evidence. An effective emulsifier package supports those development goals but cannot substitute for testing the complete agricultural product.

EMULSION IN WATER FORMULATION DEVELOPMENT

Agnique CSO-35 can support an EW in which an organic phase is already dispersed in water and the emulsifier must support that interface during storage. Agnique CSO-35 can be considered where its hydration and oil-phase compatibility provide a useful nonionic contribution. Droplet generation depends on the manufacturing route, including the phase into which each emulsifier is introduced.

A percentage list without temperature, addition sequence and shear conditions does not define a reproducible emulsion process. The aqueous phase may contain salts, rheology modifiers or other auxiliaries that alter surfactant behavior. Check their influence after the basic oil-water system is understood, rather than changing all ingredients at once.

Preservation requires assessment where microbial growth is possible in the water-containing product. Compatibility and effectiveness belong to the finished composition, especially when a preservative can distribute between water and organic droplets. Storage evaluation should include droplet growth, separation, viscosity and active assay. Those measurements help determine whether a failure originates in the interface, continuous phase, dissolved active or chemical stability of the formulation.

SUSPOEMULSIONS AND COMPETING INTERFACES

Agnique CSO-35 can be considered in a suspoemulsion containing both suspended solid material and emulsified organic droplets in an aqueous phase. The two types of interface create a more demanding design problem than an ordinary EW because they can interact with the same auxiliaries. POE 35 castor oil may support the emulsified phase while a separate particle dispersant stabilizes the solid active.

Assigning those functions clearly avoids assuming that one nonionic material automatically provides adequate adsorption on every particle surface. A surfactant can redistribute after two individually stable premixes are combined. If one interface loses protective coverage, droplet growth or particle agglomeration can appear even though each premix passed its original test.

The solvent environment can also change active solubility and encourage crystal growth. Analyze particle behavior after temperature cycling rather than relying on the initial size distribution alone. An SE qualification should track each active and both physical structures. A uniform appearance is useful but cannot establish that suspended solids, organic droplets and chemical assay all remain within their required limits.

OIL DISPERSIONS AND EMULSIFIER COMPATIBILITY

Agnique CSO-35 can be screened in an OD that holds solid active particles in a nonaqueous carrier and usually requires good dispersion after addition to water. The 35 EO castor oil emulsifier can be screened for that dilution role, provided it is compatible with the complete supplied concentrate. Its relatively hydrophilic contribution can create a challenge in a highly nonpolar carrier.

Check whether the proposed surfactant blend remains uniform during storage before assessing the emulsion formed after dilution. Particle dispersion in the OD is a different requirement from emulsification of its oil. Select an appropriate dispersant and rheology system rather than expecting the nonionic emulsifier to perform every stabilization function.

Active solubility in the liquid phase should remain compatible with the intended suspension. Excessive dissolution followed by cooling can change particle shape and size, creating a problem that more emulsifier does not resolve. Testing should separate carrier oil release from poor particle dispersion in water. These observations provide a more useful development direction than a single label stating that the dilution failed.

SUSPENSION CONCENTRATES AND SURFACTANT ADSORPTION

Agnique CSO-35 can be evaluated in an SC containing solid active particles dispersed in an aqueous continuous phase. Ethoxylated castor oil can be evaluated as an auxiliary in suitable systems, but its role should be established through the actual particle and formulation response. A wetting contribution may help introduce particles into water during manufacture, whereas long-term dispersion requires resistance to agglomeration and sediment formation.

Those functions are related but not identical. Different active surfaces can adsorb the same surfactant differently. A material that works with one technical active should not be presented as a universal stabilizer for every suspension concentrate.

Measure particle distribution, sediment character and viscosity after storage and temperature exposure. Analytical assay is also necessary when chemical degradation could occur without a visible change. If an established dispersant is already present, examine whether the added castor oil ethoxylate improves or disrupts its performance. Competition at the particle surface can make the effect of a second surfactant less predictable than its individual wetting behavior suggests.

FUNGICIDE AND MULTIPLE ACTIVE CONCENTRATES

Agnique CSO-35 can be investigated in fungicide formulation work that combines solvent selection with emulsifier optimization because active structures vary substantially. Agnique CSO-35 is useful to investigate where the selected organic phase requires a more hydrophilic nonionic contribution. Use the technical active grade intended for production and retain its assay and impurity information.

Changes in raw active can affect dissolution or emulsion behavior and otherwise be mistaken for inconsistent surfactant performance. A combination of two actives needs evaluation at the intended total loading. The pair may create a narrower solubility margin or different interfacial environment than either active alone.

Track each active analytically during storage, especially when the formulation remains visually unchanged. A clear or stable emulsion can still lose one component through chemical degradation. The useful emulsifier blend is the one that supports the complete concentrate and its dilution across the defined operating conditions. A higher EO number alone does not establish a better formulation for every fungicide combination.

HERBICIDE AND INSECTICIDE DELIVERY SYSTEMS

Agnique CSO-35 should be selected for the exact active form and carrier system because herbicide and insecticide formulations can require quite different delivery systems and exposure conditions. The nonionic emulsifier should be selected for the exact active form, formulation architecture and intended use rather than for a broad pesticide category. An ester, salt or other commercial active form can alter solubility and compatibility.

Testing a related form does not establish that the intended material will behave in the same way. For spray delivery, observe physical dilution and target contact at the actual application concentration. Measurements obtained with concentrated surfactant solutions can overstate effects that are much smaller after use dilution.

Crop tolerance and biological response require direct evidence for the finished product. Improved spreading may be useful, but it can also change exposure in ways that are undesirable for a particular crop or application condition. Document the purpose of the castor oil ethoxylate emulsifier change and the endpoint it improves. This keeps commercial claims connected to measured results rather than general assertions about stronger uptake or broader pest control.

BUILT-IN ADJUVANTS AND TANK-MIX PRODUCTS

Agnique CSO-35 can contribute to a built-in adjuvant system that forms part of a finished pesticide formulation and its qualification. Castor oil ethoxylate 35 EO can influence the physical delivery environment, but the useful level must be determined together with the active and other ingredients. A separate tank-mix product adds compatibility uncertainty because users may combine it with different registered formulations.

Test the intended combinations rather than describe nonionic character as proof of universal compatibility. Foam, standing stability and the order of addition are practical parts of the evaluation. A mixture that looks uniform under vigorous laboratory stirring may behave poorly in a partially filled application tank with limited agitation.

Water composition can shift the result, particularly in mixtures containing fertilizer salts or other electrolyte-rich products. Establish a defined water test range and include the combinations most relevant to the proposed use. Any recommended rate should follow the evidence and applicable product requirements. An ingredient percentage in an experimental adjuvant concentrate does not independently determine a safe or effective field dose.

INDUSTRIAL EMULSIONS AND PROCESS AIDS

Agnique CSO-35 can be used to investigate distribution of a suitable organic phase in water in industrial systems. Agnique CSO-35 is a screening candidate where its relatively hydrophilic balance matches the selected oil and process environment. The functional oil still supplies much of the process performance, such as lubrication or another surface effect.

The emulsifier should not be assigned those functions merely because it maintains the oil in a useful dispersed form. Circulation, temperature and contamination can change an operating emulsion. Evaluate a representative used fluid when accumulated soil or dissolved salts are likely to affect performance.

A process aid also needs compatibility with later manufacturing steps. Residues can interfere with coating, bonding or surface treatment even when the immediate emulsification task is successful. Select the formulation against the whole process sequence and specify its required condition at each stage. This makes the castor oil ethoxylate decision more commercially useful than testing only a fresh emulsion in a stationary container.

CLEANING, DEGREASING AND RINSE BEHAVIOR

Agnique CSO-35 is a nonionic castor oil derivative that can support cleaning systems by helping distribute an oily ingredient or carry an organic cleaning phase into a rinse. It should be assessed together with the solvent and other surfactants selected for the actual deposit. Wetting, soil removal and rinse cleanliness are separate endpoints.

A cleaner can spread effectively and form a stable emulsion while leaving unacceptable residue or failing to detach a cured soil. For solvent-rich cleaners, examine the entire transition as water is introduced. Intermediate compositions may thicken or separate even when the neat concentrate and final rinse mixture both look acceptable.

For aqueous cleaners, compare performance at the intended use dilution rather than only at the supplied concentration. Water hardness and decreasing surfactant levels can expose compatibility limits that are absent in a concentrated sample. The downstream treatment process belongs in the assessment because stable emulsification can make oil separation more difficult. A practical formulation balances cleaning, rinsing and waste handling rather than optimizing one stage without considering the others.

COATINGS, INKS AND ORGANIC ADDITIVE DISPERSION

Agnique CSO-35 can be screened by coating and ink developers where a hydrophobic component needs distribution in a water-rich system. These are application development possibilities requiring binder and film evaluation, not blanket approvals for every coating technology. A surfactant that emulsifies an oil is not necessarily the right dispersant for a pigment.

Particle adsorption and agglomeration need their own tests when using Agnique CSO-35, particularly when the required function is color development or stable pigment dispersion. Residual hydrophilic material can influence film water sensitivity and adhesion. Evaluate the dried film as well as the wet formulation so an improvement in initial compatibility does not undermine final performance.

Other auxiliaries can compete or interact with the added surfactant. Check compatibility with the actual binder, defoamer and rheology package rather than drawing conclusions from a simplified surfactant-water mixture. For a process additive, also examine surface defects and behavior after the more volatile ingredients leave. The final structure can differ from the initial wet system in ways important to blocking, gloss or handling strength.

COSMETIC NOMENCLATURE AND PHARMACEUTICAL DISTINCTIONS

Agnique CSO-35 is related to the ingredient chemistry described in personal care nomenclature as PEG-35 CASTOR OIL. Industrial grade selection still requires an explicit suitability statement and the impurity and quality documentation appropriate to that application. A shared name does not establish equivalence to a cosmetic-qualified or pharmaceutical-qualified product.

Specifications can differ in residual components, analytical controls and manufacturing documentation even within the same broad chemical family. Polyoxyl 35 castor oil also appears in pharmaceutical terminology, which can create misleading substitution assumptions. Agnique CSO-35 should not be assigned pharmacopoeial compliance, injectable suitability or equivalence to a specialized excipient without supporting evidence.

Hydrogenated castor oil ethoxylates must also remain distinct because hydrogenation changes the oil-derived structure. Their similar naming pattern does not make their handling or solubilization profile identical. Where an application is regulated, clarify the required grade before developing a formula around the industrial material. This prevents a technically promising project from reaching a late stage without the documents needed for commercial use.

COMPARISON WITH Agnique CSO 20 AND OTHER EO GRADES

Agnique CSO-35 generally provides a larger polyether contribution than lower EO grades within a related castor oil ethoxylate series. That distinction can be useful when the existing formulation needs a more hydrophilic nonionic balance. A lower EO material may nevertheless give better compatibility with a particular organic concentrate.

A higher EO candidate can improve water interaction while making the supplied concentrate more difficult to keep homogeneous. Grades above 35 EO offer another direction for testing, but more ethoxylation is not a universal improvement. Droplet formation, foam, temperature response and the needed anionic partner can change along with the balance.

Compare the exact grades at their useful blend ratios rather than force an unoptimized weight-for-weight replacement. The most informative trial preserves the functional target while allowing appropriate adjustment of the castor oil ethoxylate package. The selection should follow the required operating window, not an assumption that the highest number is the highest quality. Commercial quality and average EO level describe different aspects of a surfactant product.

COMPARISON WITH ALCOHOL ETHOXYLATES

Agnique CSO-35 can be compared with alcohol ethoxylates, which provide many choices of hydrophobe, EO level and physical handling. They can be excellent candidates for wetting, cleaning or emulsification, and the relevant comparison should identify the exact competing grade. The castor oil-derived architecture differs from a simple alkyl-polyether structure.

This can affect organic-phase compatibility and interfacial arrangement, providing a possible advantage in some active-containing oil systems. An alcohol ethoxylate may instead offer a useful dynamic wetting response or a different viscosity profile. A formulator should compare the practical functions rather than declare one family universally superior.

Temperature and water tests need matching conditions because both families show grade-dependent behavior. Cloud points measured in different media cannot establish a reliable ranking of application tolerance. A fair commercial comparison includes dose, co-emulsifier requirements and manufacturing effort. The candidate that meets the complete performance target consistently may be preferable even if another material has a more attractive isolated property.

COMPARISON WITH POLYSORBATES AND BLOCK COPOLYMERS

Agnique CSO-35 can be compared with polysorbates and EO-PO block copolymers, which offer different molecular architectures for nonionic stabilization. Their broad functional overlap with ethoxylated castor oil does not establish identical behavior at an oil-water interface. The 35 EO castor oil derivative can be useful when its oil-derived portion and hydrated chains fit the chosen carrier.

Another nonionic structure may provide a better balance of foam, temperature response or compatibility in a different formulation. HLB estimates can help frame a trial but cannot fully compare those structures. The amount of material needed, adsorption behavior and tolerance to salts may differ even when nominal values appear similar.

Consider the grade's application documentation as well as its performance. A surfactant qualified for one regulated use does not transfer its status to another family member selected for a technical comparison. Replacement development should allow controlled optimization rather than a single arbitrary recipe. If a promising candidate needs a different partner ratio, that adjustment is part of the comparison rather than evidence that the Agnique CSO-35 material has failed.

DIFFERENCE FROM SULFATED, SULFONATED AND HYDROGENATED OILS

Agnique CSO-35 is an ethoxylated oil-derived material, distinct from oils modified through sulfation, sulfonation or hydrogenation. An anionic modified castor oil is therefore not an interchangeable synonym or direct chemical equivalent of this nonionic grade. Hydrogenation changes the unsaturated oil-derived structure and can alter physical properties.

Unlike Agnique CSO-35, a hydrogenated castor oil ethoxylate needs its own qualification even when its average EO level is similar. These distinctions are important because catalogue synonym lists sometimes group several modified castor oil products together. The shared botanical source can conceal differences that affect dilution, storage and compatibility.

An Agnique CSO-35 purchasing specification should identify the modification route and approximate EO level, along with the commercial grade. This is more precise than a request for castor oil emulsifier without further description. Confirm the sample identity before beginning formulation work. An incorrect chemical variant can produce misleading results and lead to a recipe that cannot be reproduced with the intended raw material.

ANIONIC PARTNERS AND BLEND RATIO SELECTION

Agnique CSO-35 can be combined with an anionic partner that complements its nonionic hydration-based contribution. Calcium dodecylbenzene sulfonate products are a relevant example in suitable organic crop protection formulations. Manufacturer information for one specific anionic grade describes an anionic-to-nonionic starting ratio of approximately one to two.

That is useful orientation for a first trial, not a universal ratio for all actives, solvents or commercial surfactant concentrations. Correct for the active concentration and carrier solvent of the anionic product being used. Equal charges of two commercial solutions may supply different amounts of functional emulsifier and different organic liquids.

For Agnique CSO-35 blends, start with ratio comparisons at a fixed total package level, then investigate total dosage around the promising region. This separates improved balance from the effect of simply adding more surfactant. The best blend should preserve concentrate compatibility and dilution performance together. A package that emulsifies well in water but separates before use is not a satisfactory commercial solution.

FORMULATION EXPERIMENT DESIGN

Agnique CSO-35 should be evaluated with a useful trial plan that begins with a clear failure mode and measurable acceptance criteria. Free oil, active crystals, excessive foam and gel formation call for different experiments, even when they all appear under the general heading formulation instability. Keep the active-containing phase constant while varying the emulsifier package so the first comparison has a clear interpretation.

Once a useful surfactant region is identified, examine carrier or auxiliary changes separately. Use test water with known characteristics and document the addition sequence. Otherwise, differences in hardness or local mixing can obscure the effect of the castor oil ethoxylate ingredient being evaluated.

Include the currently accepted formulation as a control and retain samples for relevant storage comparisons. A promising candidate should outperform or adequately match the baseline under the conditions that matter to the project. Write observations in terms that can guide the next action. A record of phase separation after a defined standing time is more useful than a comment that one blend looked worse than another.

STARTING FORMULAS AND THEIR DEVELOPMENT STATUS

Agnique CSO-35 is included in the following original laboratory screening proposals expressed as percentages by weight. They illustrate formulation architectures and are not manufacturer-certified commercial recipes, approved pesticides or evidence of suitability for unspecified active ingredients. Each composition totals 100%, with balancing carrier or water available for justified adjustments.

Every ingredient described by function requires selection of a specific compatible commercial grade before a reproducible trial can be performed. If a target is stated on a pure active basis, correct the technical active charge for its assay. Also account for water or solvent present in supplied surfactant, dispersant and rheology modifier products.

Preservatives, defoamers and other auxiliaries should be added only after selection for the actual application, with their charge deducted from the balancing phase. Retest the system after any addition that can change interfacial or continuous-phase behavior. These proposals support comparison work rather than final production release. Physical stability, chemical assay, application response, packaging and the relevant regulatory requirements determine whether a developed version is commercially suitable.

EC STARTING FORMULA WITH A NONIONIC-ANIONIC PACKAGE

- Compatible technical active ingredient: 12.0%
- Agnique CSO-35: 6.0%
- Selected compatible anionic emulsifier product: 3.0%
- Compatible primary organic carrier: 49.0%
- Compatible secondary organic carrier: 30.0%
- Total: 100.0%

Agnique CSO-35 is included in this starting point, which uses a two-to-one nonionic-to-anionic charge ratio to investigate a dissolved-active concentrate. The active and carrier must first demonstrate adequate solubility at the proposed loading across the required temperature range. Prepare the solvent-active mixture and observe it before adding the surfactants.

When blending Agnique CSO-35, include any solvent carried by the anionic emulsifier in the final phase composition when interpreting the results. Compare neighboring ratios at the same nine percent total package level, then evaluate whether a different total amount is needed. This design makes the role of the 35 EO castor oil contribution easier to interpret. Accept the sample only against defined concentrate and dilution criteria. Crop safety, chemical stability and packaging qualification remain necessary before a developed formulation can be adopted for agricultural use.

EW STARTING FORMULA FOR AN ORGANIC ACTIVE PHASE

- Compatible technical active ingredient: 5.0%
- Compatible organic solvent: 20.0%
- Agnique CSO-35: 4.0%
- Selected compatible co-emulsifier: 2.0%
- Compatible aqueous rheology modifier product: 0.2%
- Water: 68.8%
- Total: 100.0%

Agnique CSO-35 is included in this proposal exploring an oil-in-water product with the active dissolved inside organic droplets. The selected solvent must maintain adequate active solubility before the emulsifier package can be meaningfully evaluated. Define phase preparation and addition sequence according to the specific surfactants and rheology modifier.

With Agnique CSO-35, a change in sequence can alter droplet formation and local gel behavior even when the final recipe is identical. Select preservation separately if required and deduct the charge from water. The final composition needs both physical and microbiological suitability for its intended storage and application. Measure droplet distribution, separation, viscosity and active assay after relevant exposure. An attractive initial emulsion is only the beginning of the qualification rather than evidence of a validated commercial shelf life.

OD STARTING FORMULA FOR A SUITABLE PARTICULATE ACTIVE

- Selected insoluble technical active ingredient: 20.0%
- Compatible carrier oil blend: 60.0%
- Agnique CSO-35: 4.0%
- Selected compatible co-emulsifier: 9.0%
- Selected oil-phase particle dispersant: 5.0%
- Compatible oil-phase rheology modifier: 2.0%
- Total: 100.0%

Agnique CSO-35 is included at a relatively modest fraction intended to test its contribution to water dilution without assuming complete compatibility with every oil carrier. Screen the liquid blend before milling and reject persistent phase separation unless a validated process specifically requires that architecture. Determine whether the active remains sufficiently insoluble in the complete liquid phase.

In Agnique CSO-35 oil-dispersion studies, dissolution and later recrystallization can undermine particle stability even when milling initially produces the desired distribution. Use the activation procedure required by the selected rheology modifier and monitor both flow and sediment character. A high resting viscosity is not a complete substitute for a reproducible suspension structure. Evaluate free oil and solid dispersion separately after water addition. The resulting diagnosis should determine whether to change the castor oil ethoxylate emulsifier ratio, dispersant or organic carrier rather than simply increase every auxiliary.

SE STARTING FORMULA FOR A DUAL ACTIVE SYSTEM

- Selected suspended technical active ingredient: 10.0%
- Selected oil-soluble technical active ingredient: 5.0%
- Compatible organic solvent: 15.0%
- Agnique CSO-35: 3.0%
- Selected compatible co-emulsifier: 2.0%
- Selected aqueous particle dispersant: 2.0%
- Compatible aqueous rheology modifier product: 0.3%
- Water: 62.7%
- Total: 100.0%

Agnique CSO-35 is included in this example, which separates the stabilization of suspended particles from the stabilization of active-containing organic droplets. Confirm that the suspended active does not dissolve excessively in the final aqueous-solvent environment before choosing milling and homogenization conditions. Assess the particle dispersion and emulsion premixes individually, then examine the effect of combining them.

Redistribution of Agnique CSO-35 and other surfactants can change the behavior of either interface after contact with the other phase. Track each active analytically and observe particle size, droplet distribution and sediment character. A stable emulsion alone does not establish a satisfactory suspoemulsion if the solid component agglomerates or recrystallizes.

RINSEABLE INDUSTRIAL CLEANER STARTING FORMULA

- Selected compatible ester cleaning solvent: 45.0%
- Selected compatible secondary solvent: 40.0%
- Agnique CSO-35: 8.0%
- Selected compatible co-emulsifier: 7.0%
- Total: 100.0%

Agnique CSO-35 is included in this solvent-rich proposal testing the ability of a mixed emulsifier package to support rinsing from resistant industrial substrates. Select solvents against the actual deposit and verify that the complete concentrate remains uniform before evaluating cleaning performance. The relatively hydrophilic nonionic ingredient may require a suitable co-emulsifier to remain compatible with the organic phase.

Compare intermediate rinse dilutions because the mixture can thicken or separate along the path to the final water-rich condition. Measure soil removal, clean-substrate damage and remaining residue separately. The finished cleaner also requires its own exposure and flash point assessment, which cannot be inferred from the neat surfactant.

AQUEOUS EMULSION CLEANER STARTING FORMULA

- Selected compatible cleaning solvent: 8.0%
- Agnique CSO-35: 3.0%
- Selected compatible co-emulsifier: 2.0%
- Selected compatible hydrotrope product: 2.0%
- Water: 85.0%
- Total: 100.0%

Agnique CSO-35 is included in this example exploring an emulsified cleaning solvent in a water-rich industrial product. Choose the hydrotrope and co-emulsifier for the actual solvent, water chemistry and cleaning requirement rather than treating their functional descriptions as complete ingredient specifications. Use a documented addition sequence that avoids persistent concentrated surfactant-water regions.

If preservation or foam control is required, select those auxiliaries separately and deduct their amounts from water. Evaluate the cleaner at its intended use dilution as well as at supplied concentration. Successful emulsification must be accompanied by adequate soil removal, substrate compatibility and acceptable rinse behavior.

SAMPLE PREPARATION AND REPRESENTATIVE SAMPLING

Agnique CSO-35 requires a raw material sample that represents the whole container rather than only its easiest-flowing portion. Temperature-related nonuniformity should be addressed with the applicable supplier procedure before a laboratory dose is withdrawn. Record sample temperature and history when viscosity or appearance is part of the acceptance decision.

A recently warmed sample can behave differently from material equilibrated under ordinary storage conditions. Clean sampling equipment helps avoid trace water or other surfactant contamination that changes concentrate behavior. Where sampling is repeated, reseal the original package promptly to limit moisture uptake. Retain enough identity information to connect the sample with its commercial grade and batch. This makes a later production comparison meaningful and supports investigation if a delivery behaves differently from the qualified material.

SCALE-UP AND MANUFACTURING CONTROL

Agnique CSO-35 emulsion processing requires more than multiplying ingredient weights when scaling up. Vessel geometry, mixing intensity, addition location and heat transfer determine how quickly local composition differences are eliminated. The dilution-related thickening of ethoxylated castor oil makes local mixing especially relevant.

An Agnique CSO-35 laboratory route that passes rapidly through a viscous intermediate can create a persistent gel region in a larger tank if the addition point is poorly chosen. Define measurable process endpoints, including phase uniformity and a relevant droplet or particle distribution. These give operators a clearer control basis than instructions to mix until the Agnique CSO-35 product appears acceptable. Pilot manufacture should compare dissolution, emulsion formation, temperature and final uniformity with the laboratory procedure. Any correction made during the pilot needs to be recorded as part of the process or formulation rather than left as an undocumented adjustment.

STORAGE AND MOISTURE CONTROL

Store Agnique CSO-35 in its original closed packaging in a dry location under the current manufacturer conditions. Hygroscopic behavior makes prompt resealing important whenever material is removed. Moisture uptake can influence an organic concentrate even when the raw emulsifier does not show an obvious appearance change.

For Agnique CSO-35, control handling practices and establish a water acceptance criterion where the application is sensitive. The manufacturer technical information describes a shelf life of at least 24 months under appropriate sealed original-package storage. Apply the statement relevant to the actual supply and retain the batch and storage history needed to assess conformity. Avoid treating prolonged heated storage as equivalent to ordinary warehouse storage. Where a heated tank is needed, follow the grade-specific requirements for temperature control, mixing and protection from air contact.

COLD RECOVERY AND HEATING PRACTICE

Agnique CSO-35 can undergo cold-related changes in uniformity and handling without necessarily being destroyed. Follow the applicable manufacturer recovery instructions and evaluate whether the material returns to an acceptable condition before use. Heating should be gentle and controlled to avoid localized exposure that can discolor or damage material.

Equipment suitability and mixing matter as much as the average measured temperature of the container. Persistent sediment, unexpected odor or failure to recover normal behavior deserves investigation. Do not classify every change as harmless cold clouding simply because the Agnique CSO-35 product is known to have temperature-sensitive properties. The raw surfactant and an active-containing finished formulation require separate decisions. Restoring emulsifier uniformity does not establish that a concentrate exposed to cold remains chemically stable or free of active crystals.

PUMPING AND MATERIAL COMPATIBILITY

Agnique CSO-35 transfer equipment should be selected using viscosity measured at the actual operating temperature and representative material condition. Historical values with conflicting room-temperature entries should be resolved before they control pump sizing or transfer limits. The complete formulation may have viscosity unlike the neat emulsifier because water, solvents and surfactants can create structured mixtures.

Direct measurement is more useful than a weighted average of individual ingredient viscosities. Assess tank, seal, gasket and closure compatibility with the Agnique CSO-35 material each component will contact. Suitable stainless steel storage information does not independently establish resistance of every polymeric seal or packaging liner. Packaging tests should include temperature, orientation and contact time representative of storage and transport. Leakage or closure damage can be commercially significant even when the bottle body itself remains acceptable.

QUALITY CONTROL AND BATCH ACCEPTANCE

Agnique CSO-35 incoming control should match the exact supplied grade with its agreed specification and batch documentation. Appearance checks are useful, but they should distinguish normal temperature-related behavior from contamination or an incorrect product. Properties such as acid value, saponification value, moisture and defined cloud point can provide useful quality indicators where they are part of the approved specification.

Compare results only when test preparation and temperature are equivalent. A retained-sample comparison helps determine whether a formulation failure follows a raw material change. Include the active, solvent and partner emulsifier in the investigation because the nonionic castor oil ethoxylate is only one possible source of variation. Commercial release should use approved limits and a defined response to nonconformity. A shared CAS number or urgent production requirement does not make an unqualified EO grade equivalent to the established material.

TDS, SDS AND COA DOCUMENTATION

Agnique CSO-35 technical data sheets (TDS) describe identity, typical properties, handling and application context. Its typical figures should not be converted into guaranteed acceptance limits unless the agreed specification explicitly does so. The SDS addresses hazards, workplace handling, emergency information and relevant classification.

Obtain the current document appropriate to the supplied grade and market rather than relying on general statements about nonionic surfactants. The COA relates to a particular batch and its specified quality results or conformity. Match the Agnique CSO-35 product designation and batch with the delivered package before using it for incoming acceptance. Additional application declarations may be required, especially for regulated uses. Their availability should be confirmed explicitly instead of inferred from a related INCI name or the reputation of the chemical family.

WORKPLACE SAFETY AND EMERGENCY HANDLING

Agnique CSO-35 is nonionic and derived in part from plant feedstock, but those characteristics do not establish that the material is harmless. The current Agnique CSO-35 SDS and the actual exposure conditions should determine handling controls and protective equipment. Avoid uncontrolled contact, splashing and aerosol formation during mixing or transfer.

Heated processing and spray use can create exposure conditions different from ordinary drum withdrawal. A solvent-containing finished formulation may require precautions different from those appropriate to the neat emulsifier. Assess the blend as a whole because another ingredient can control glove compatibility, fire precautions or ventilation needs. For exposure incidents, follow the applicable safety instructions and obtain appropriate medical advice. Ensure that workers can access the correct product identification and emergency facilities without relying on an informal description such as castor oil additive.

SPILLS AND WASTE HANDLING

Agnique CSO-35 spills require collection and disposal according to current safety instructions. A surfactant spill can also create a slippery working surface that requires prompt controlled cleanup. Waste characteristics depend on the complete mixture, including any active ingredient, solvent or dissolved soil. The disposal route for Agnique CSO-35 should not be assigned solely from the nonionic emulsifier's family description.

REGULATORY AND APPLICATION SUITABILITY

Agnique CSO-35 chemical identity and suitability for a finished product are separate questions. The intended market, use, concentration and exposure determine the documentation and assessment required for commercial selection. For agricultural use, evaluate the co-formulant within the applicable pesticide formulation and authorization framework.

A manufacturer application listing cannot independently approve every recipe or active combination. Cosmetic, food-contact and pharmaceutical projects need their own grade and impurity requirements. Do not assign these statuses to an industrial emulsifier from a shared name or registry number. Review the qualification when a market, formulation or use changes. Stable chemical principles can support an evergreen technical page, while each supply decision still needs the applicable requirements at the time of purchase.

PRICE, COST IN USE AND SUPPLIER QUALIFICATION

Agnique CSO-35 price comparisons should include the delivered grade, quantity, packaging and commercial terms. Functional dosage and the amount of partner surfactant required can change the cost of a formulation that actually meets its targets. Manufacturing effort also matters, including warming, homogenization, transfer losses and cleaning.

A lower unit price for Agnique CSO-35 or an alternative may provide little benefit if a nominal equivalent creates additional processing or inconsistent batches. Compare candidate suppliers against the same specification and performance trial. EO level, composition distribution and documentation must match the application requirements rather than simply share the family CAS number.

A useful enquiry states the exact product name, intended formulation architecture, expected quantity and required documents. Include critical performance needs such as hard-water dilution, cold handling or an organic-phase compatibility limit so the response addresses a concrete purchasing decision.

FREQUENTLY ASKED QUESTIONS ABOUT Agnique CSO-35

What is Agnique CSO-35 used for?
It is principally a nonionic emulsifier for suitable agricultural and industrial formulation systems. Manufacturer context includes EC, EW, SE and OD architectures, with wetting and adjuvant contributions evaluated in the finished product.

What is its chemical identity?
It is castor oil ethoxylate with approximately 35 EO on average. Related descriptions include POE 35 castor oil and polyoxyethylene castor oil.

What are its CAS and EC numbers?
The family CAS number is 61791-12-6 and the EC / List number is 500-151-7. These should be used together with the exact grade because they do not independently specify the average EO level.

What INCI name is related to this chemistry?
PEG-35 CASTOR OIL is the related ingredient nomenclature. Confirm the declaration and cosmetic suitability of the supplied commercial grade before using it for a regulated personal care product.

Is it a pure compound with one molecular weight?
Commercial ethoxylated castor oil contains a distribution of related components. A single exact molecular formula or definitive molecular weight would misrepresent that composition.

Can it replace a pharmaceutical polyoxyl 35 castor oil excipient?
An industrial product should not be assigned pharmacopoeial equivalence or pharmaceutical suitability without the required evidence. Shared chemical terminology is insufficient to establish interchangeable quality.

Why do different cloud point values appear?
The test methods use different media that change surfactant hydration and phase behavior. Retain the method with the value and test the actual finished formulation for its operating range.

Which viscosity should be used for pumping calculations?
Use a verified value measured under representative operating conditions. The historical room-temperature entries are inconsistent, so current confirmation or direct measurement is necessary for equipment selection.

Can water addition cause gel formation?
Intermediate surfactant-water compositions can become much more viscous than either the neat material or final dilute mixture. A defined addition route and suitable mixing should be established during development.

Does a clear water test prove universal solubility?
Compatibility depends on concentration, temperature and other ingredients. A clear test mixture does not establish that every organic active, solvent or electrolyte-rich formulation will behave similarly.

Can it be paired with anionic emulsifiers?
Compatible anionic partners can complement its nonionic contribution, and calcium dodecylbenzene sulfonate is a relevant example. Optimize the ratio against the actual carrier and account for the concentration of each commercial product.

Does more EO always improve emulsification?
A higher average EO level changes the balance but does not create universal superiority. A lower or higher grade may fit another oil phase or process better.

Is it the same as hydrogenated castor oil ethoxylate?
Hydrogenation changes the oil-derived structure and can change physical behavior. Hydrogenated grades need separate identity and performance qualification.

Is it equivalent to Turkey red oil?
Turkey red oil describes sulfated castor oil chemistry rather than this nonionic ethoxylated grade. The materials should not be listed or purchased as interchangeable synonyms.

Does it guarantee better pesticide uptake?
Wetting and emulsification can affect the delivery environment but do not guarantee improved uptake or efficacy. Biological claims require tests on the finished product at the proposed use conditions.

Can it serve as the only particle dispersant?
A particle surface may require a different stabilization mechanism from an oil-water interface. Evaluate a suitable dedicated dispersant where the suspension architecture requires it.

Are the starting formulas ready for commercial use?
They are laboratory comparison proposals that require specific compatible ingredients and full qualification. They do not establish registered use, shelf life, efficacy or substrate safety.

What documents should a buyer request?
Request the grade-specific TDS, applicable SDS, agreed specification and available batch COA. Add application declarations according to the intended market and quality requirements.

How should a generic alternative be evaluated?
Compare identity, EO level, quality limits and performance under the same trial conditions as the approved product. Matching CAS alone does not establish functional equivalence.

What information should be sent to Ataman Kimya?
Provide the exact designation, intended formulation, carrier or active system, expected quantity and required documents. State the critical acceptance criteria so technical and commercial discussion can focus on the process.

AGNIQUE CSO-35 SUPPLY FROM ATAMAN KIMYA

Agnique CSO-35 can be discussed with Ataman Kimya by providing the exact product name and a description of the intended formulation or manufacturing operation. Identifying the active-containing phase, target concentration and dilution conditions gives the enquiry a useful technical basis. Ask for confirmation of the proposed grade and availability of its relevant TDS, SDS, specification and batch documentation.

Where viscosity, moisture or cloud point controls acceptance, include the required method and condition so the response can be evaluated against the actual process. For a qualification sample, define the comparison with the current emulsifier package before testing. Concentrate compatibility, dilution stability, temperature behavior and application performance provide a concrete basis for deciding whether the 35 EO castor oil derivative belongs in the formulation. Current availability, packaging, lead time and commercial terms should be confirmed for the requested delivery. A focused enquiry enables a documented discussion with Ataman Kimya and helps connect material selection with the technical and purchasing requirements of the finished product.